S&P 500   4,577.10
DOW   34,639.79
QQQ   389.91
S&P 500   4,577.10
DOW   34,639.79
QQQ   389.91
S&P 500   4,577.10
DOW   34,639.79
QQQ   389.91
S&P 500   4,577.10
DOW   34,639.79
QQQ   389.91

National Health Investors Stock Forecast, Price & News

+2.28 (+4.47%)
(As of 12/2/2021 04:00 PM ET)
Today's Range
50-Day Range
52-Week Range
368,822 shs
Average Volume
311,394 shs
Market Capitalization
$2.44 billion
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive NHI News and Ratings via Email

Sign-up to receive the latest news and ratings for National Health Investors and its competitors with MarketBeat's FREE daily newsletter.

National Health Investors logo

About National Health Investors

National Health Investors, Inc. is a real estate investment trust, which engages in the sale-leaseback, joint-venture, mortgage, and mezzanine financing of senior housing and medical investments. Its portfolio includes lease, mortgage and other note investments in independent living facilities, assisted living facilities, entrance-fee communities, senior living campuses, skilled nursing facilities, specialty hospitals, and medical office buildings. The company was founded by W. Andrew Adams in 1991 and is headquartered in Murfreesboro, TN.


See More Headlines

Industry, Sector and Symbol

Real estate investment trusts
Specialized REITs
Year Founded

Sales & Book Value

Annual Sales
$332.81 million
Cash Flow
$5.68 per share
Book Value
$33.79 per share


Net Income
$185.13 million
Pretax Margin




Free Float
Market Cap
$2.44 billion

Company Calendar

Dividend Payable
Last Earnings
Fiscal Year End
Next Earnings (Estimated)

Social Links


Overall MarketRank

2.83 out of 5 stars

Finance Sector

112th out of 1,340 stocks

Real Estate Investment Trusts Industry

18th out of 223 stocks

Analyst Opinion: 3.0Community Rank: 3.9Dividend Strength: 3.3Insider Behavior: 3.3Valuation: 0.6 5 -4 -3 -2 -1 -

National Health Investors (NYSE:NHI) Frequently Asked Questions

Is National Health Investors a buy right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for National Health Investors in the last year. There are currently 1 sell rating, 5 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" National Health Investors stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NHI, but not buy additional shares or sell existing shares.
View analyst ratings for National Health Investors
or view top-rated stocks.

How has National Health Investors' stock been impacted by Coronavirus (COVID-19)?

National Health Investors' stock was trading at $70.86 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, NHI stock has decreased by 24.9% and is now trading at $53.24.
View which stocks have been most impacted by COVID-19

Are investors shorting National Health Investors?

National Health Investors saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 1,350,000 shares, an increase of 18.4% from the October 31st total of 1,140,000 shares. Based on an average daily volume of 318,300 shares, the short-interest ratio is currently 4.2 days. Currently, 3.1% of the shares of the company are sold short.
View National Health Investors' Short Interest

When is National Health Investors' next earnings date?

National Health Investors is scheduled to release its next quarterly earnings announcement on Monday, February 28th 2022.
View our earnings forecast for National Health Investors

How were National Health Investors' earnings last quarter?

National Health Investors, Inc. (NYSE:NHI) announced its earnings results on Monday, November, 8th. The real estate investment trust reported $0.67 earnings per share for the quarter, missing the consensus estimate of $1.18 by $0.51. The real estate investment trust had revenue of $73.83 million for the quarter, compared to analysts' expectations of $74.21 million. National Health Investors had a trailing twelve-month return on equity of 9.20% and a net margin of 45.92%. National Health Investors's revenue for the quarter was down 12.4% on a year-over-year basis. During the same period in the previous year, the company posted $1.42 EPS.
View National Health Investors' earnings history

How often does National Health Investors pay dividends? What is the dividend yield for National Health Investors?

National Health Investors announced a quarterly dividend on Monday, November 8th. Investors of record on Friday, December 31st will be given a dividend of $0.90 per share on Monday, January 31st. This represents a $3.60 dividend on an annualized basis and a yield of 6.76%. The ex-dividend date of this dividend is Thursday, December 30th.
View National Health Investors' dividend history

Is National Health Investors a good dividend stock?

National Health Investors pays an annual dividend of $3.60 per share and currently has a dividend yield of 7.06%. NHI has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. National Health Investors has been increasing its dividend for 20 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of National Health Investors is 115.02%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, National Health Investors will have a dividend payout ratio of 75.63% in the coming year. This indicates that National Health Investors may not be able to sustain their current dividend.
View National Health Investors' dividend history.

What price target have analysts set for NHI?

7 analysts have issued 12 month target prices for National Health Investors' shares. Their forecasts range from $55.00 to $77.00. On average, they expect National Health Investors' stock price to reach $67.17 in the next year. This suggests a possible upside of 26.2% from the stock's current price.
View analysts' price targets for National Health Investors
or view top-rated stocks among Wall Street analysts.

Who are National Health Investors' key executives?

National Health Investors' management team includes the following people:
  • D. Eric Mendelsohn, President, Chief Executive Officer & Director
  • John L. Spaid, Chief Financial Officer & Executive VP-Finance
  • David Louis Travis, Chief Accounting Officer & Senior Vice President
  • Kevin C. Pascoe, Chief Investment Officer
  • Kristin Sallee Gaines, Chief Credit Officer

What other stocks do shareholders of National Health Investors own?

Based on aggregate information from My MarketBeat watchlists, some companies that other National Health Investors investors own include AT&T (T), AbbVie (ABBV), Verizon Communications (VZ), Cisco Systems (CSCO), Annaly Capital Management (NLY), JPMorgan Chase & Co. (JPM), Simon Property Group (SPG), Energy Transfer (ET), QUALCOMM (QCOM) and Broadcom (AVGO).

What is National Health Investors' stock symbol?

National Health Investors trades on the New York Stock Exchange (NYSE) under the ticker symbol "NHI."

Who are National Health Investors' major shareholders?

National Health Investors' stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (9.58%), Goldman Sachs Group Inc. (2.37%), Macquarie Group Ltd. (2.18%), Bank of New York Mellon Corp (1.95%), Geode Capital Management LLC (1.85%) and American Century Companies Inc. (1.25%). Company insiders that own National Health Investors stock include D Eric Mendelsohn, Kevin Carlton Pascoe, Robert G Adams, Robert T Webb and W Andrew Adams.
View institutional ownership trends for National Health Investors

Which institutional investors are selling National Health Investors stock?

NHI stock was sold by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, Gradient Investments LLC, BlackRock Inc., Deutsche Bank AG, Millennium Management LLC, Two Sigma Advisers LP, CapWealth Advisors LLC, and Schonfeld Strategic Advisors LLC.
View insider buying and selling activity for National Health Investors
or view top insider-selling stocks.

Which institutional investors are buying National Health Investors stock?

NHI stock was bought by a variety of institutional investors in the last quarter, including Sumitomo Mitsui Trust Holdings Inc., Macquarie Group Ltd., Nordea Investment Management AB, Barclays PLC, UBS Group AG, Nepsis Inc., American Century Companies Inc., and Cubist Systematic Strategies LLC. Company insiders that have bought National Health Investors stock in the last two years include Robert G Adams, Robert T Webb, and W Andrew Adams.
View insider buying and selling activity for National Health Investors
or or view top insider-buying stocks.

How do I buy shares of National Health Investors?

Shares of NHI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is National Health Investors' stock price today?

One share of NHI stock can currently be purchased for approximately $53.24.

How much money does National Health Investors make?

National Health Investors has a market capitalization of $2.44 billion and generates $332.81 million in revenue each year. The real estate investment trust earns $185.13 million in net income (profit) each year or $3.13 on an earnings per share basis.

How many employees does National Health Investors have?

National Health Investors employs 20 workers across the globe.

When was National Health Investors founded?

National Health Investors was founded in 1991.

What is National Health Investors' official website?

The official website for National Health Investors is www.nhireit.com.

Where are National Health Investors' headquarters?

National Health Investors is headquartered at 222 ROBERT ROSE DRIVE, MURFREESBORO TN, 37129.

How can I contact National Health Investors?

National Health Investors' mailing address is 222 ROBERT ROSE DRIVE, MURFREESBORO TN, 37129. The real estate investment trust can be reached via phone at (615) 890-9100, via email at [email protected], or via fax at 615-225-3030.

This page was last updated on 12/3/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.